Compare Abeona Therapeutics Inc (ABEO) vs Adaptive Biotechnologies Corp (ADPT) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Abeona Therapeutics Inc vs Adaptive Biotechnologies Corp — how do they compare? Abeona Therapeutics Inc trades at $7.57 (market cap $421.19M), while Adaptive Biotechnologies Corp trades at $25.5 (market cap $4.04B). The key difference: Adaptive Biotechnologies Corp is far larger — about 9.6× Abeona Therapeutics Inc's market cap. Which is the better fit depends on your goals.
| ABEO | ADPT | |
|---|---|---|
Market Cap | $421.19M | $4.04B |
Sector | Health | Health |
52-Week High | $7.45 | $25.45 |
52-Week Low | $4.17 | $12.30 |
Enterprise Value | $276.10M | $4.10B |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About Abeona Therapeutics Inc
Abeona Therapeutics develops gene and cell therapies for rare diseases. Its lead product, ZEVASKYN, is an FDA-approved therapy for recessive dystrophic epidermolysis bullosa (RDEB), a severe and life-threatening genetic skin disorder.
Read more on ABEO →About Adaptive Biotechnologies Corp
Adaptive Biotechnologies Corp is a commercial-stage company advancing the field of immune-driven medicine by harnessing the inherent biology of the adaptive immune system to transform the diagnosis and treatment of disease. Its clinical diagnostic product, clonoSEQ, is test authorized by the FDA for the detection and monitoring of minimal residual disease in patients with select blood cancers.
Read more on ADPT →
